These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22968971)

  • 21. Pneumococcal antibody levels in children with PID receiving immunoglobulin.
    Tuerlinckx D; Florkin B; Ferster A; De Schutter I; Chantrain C; Haerynck F; Philippet P; Strengers P; Laub R
    Pediatrics; 2014 Jan; 133(1):e154-62. PubMed ID: 24366995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infections.
    Ferrara G; Zumla A; Maeurer M
    Am J Med; 2012 Oct; 125(10):1036.e1-8. PubMed ID: 22608788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment Satisfaction with Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency: a Pooled Analysis of Six Hizentra® Studies.
    Mallick R; Jolles S; Kanegane H; Agbor-Tarh D; Rojavin M
    J Clin Immunol; 2018 Nov; 38(8):886-897. PubMed ID: 30465179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Profile, Dosing, and Quality-of-Life Outcomes in Primary Immune Deficiency Patients Treated at Home with Immunoglobulin G: Data from the IDEaL Patient Registry.
    Kearns S; Kristofek L; Bolgar W; Seidu L; Kile S
    J Manag Care Spec Pharm; 2017 Apr; 23(4):400-406. PubMed ID: 28345437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low Rates of Poliovirus Antibodies in Primary Immunodeficiency Patients on Regular Intravenous Immunoglobulin Treatment.
    Costa-Carvalho BT; Sullivan KE; Fontes PM; Aimé-Nobre F; Gonzales IGS; Lima ES; Granato C; de Moraes-Pinto MI
    J Clin Immunol; 2018 Jul; 38(5):628-634. PubMed ID: 30006913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative Evidence of Wear-Off Effect at the End of the Intravenous IgG (IVIG) Dosing Cycle in Primary Immunodeficiency.
    Rojavin MA; Hubsch A; Lawo JP
    J Clin Immunol; 2016 Apr; 36(3):210-9. PubMed ID: 26910102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies.
    Wolf HH; Davies SV; Borte M; Caulier MT; Williams PE; Bernuth HV; Egner W; Sklenar I; Adams C; Späth P; Morell A; Andresen I
    Vox Sang; 2003 Jan; 84(1):45-53. PubMed ID: 12542733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supply, use, and abuse of intravenous immunoglobulin.
    Nowak-Wegrzyn A; Lederman HM
    Curr Opin Pediatr; 1999 Dec; 11(6):533-9. PubMed ID: 10590912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution physicochemical characterization of different intravenous immunoglobulin products.
    Washburn N; Meccariello R; Hu S; Hains M; Bhatnagar N; Sarvaiya H; Kapoor B; Schaeck J; Pino I; Manning A; Lansing JC; Bosques CJ
    PLoS One; 2017; 12(7):e0181251. PubMed ID: 28759653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The patient: Emerging clinical applications of intravenous immunoglobulin.
    Harvey RD
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):85S-93S. PubMed ID: 16229679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Subcutaneous immunoglobulin substitution and therapy].
    Gulácsy V; Maródi L
    Orv Hetil; 2011 Jan; 152(2):64-7. PubMed ID: 21177233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex
    Wasserman RL; Melamed IR; Stein MR; Jolles S; Norton M; Moy JN;
    J Clin Immunol; 2017 Apr; 37(3):301-310. PubMed ID: 28316003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetic modeling and simulation of immunoglobulin exposure with varying dosing intervals of subcutaneous immunoglobulin 20% (Ig20Gly) in patients with primary immunodeficiency diseases.
    Dumas T; Berry NS; Wolfsegger M; Jolles S; McCoy B; Yel L
    Int Immunopharmacol; 2019 Jun; 71():404-410. PubMed ID: 30952104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain.
    Alsina L; Montoro JB; Moral PM; Neth O; Pica MO; Sánchez-Ramón S; Presa M; Oyagüez I; Casado MÁ; González-Granado LI
    Eur J Health Econ; 2022 Apr; 23(3):551-558. PubMed ID: 34546485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gammaplex
    Wasserman RL
    Immunotherapy; 2017 Oct; 9(13):1071-1088. PubMed ID: 29032734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient?
    Abolhassani H; Asgardoon MH; Rezaei N; Hammarstrom L; Aghamohammadi A
    Expert Rev Clin Immunol; 2015; 11(11):1229-43. PubMed ID: 26289377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic indications of intravenous immunoglobulins].
    Tellier Z; Mouthon L
    Transfus Clin Biol; 2003 Jun; 10(3):179-84. PubMed ID: 12798854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency.
    Visentin A; Molinari MC; Pravato S; Cellini A; Angotzi F; Cavaretta CA; Ruocco V; Imbergamo S; Piazza F; Proietti G; Mauro FR; Trentin L
    Curr Oncol; 2022 Dec; 30(1):274-283. PubMed ID: 36661671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in gammaglobulin therapy for immunodeficiency: from subcutaneous to intravenous infusions and back again.
    Wasserman RL
    J Clin Immunol; 2012 Dec; 32(6):1153-64. PubMed ID: 22828788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of patients with primary antibody deficiencies in Germany].
    Borte M; Oertelt C; Högy B
    Klin Padiatr; 2005; 217(5):276-80. PubMed ID: 16167275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.